Vitamin D and COVID-19: It is time to act #MMPMID33012103
Bleizgys A
Int J Clin Pract 2021[Mar]; 75 (3): e13748 PMID33012103show ga
Vitamin D (VitD) deficiency is considered a global problem and might be associated with increased susceptibility to COVID-19 illness. In the light of COVID-19 pandemic, VitD might be a promising agent for fighting the SARS-CoV-2, since VitD is involved in various pathophysiological mechanisms that occur during COVID-19 infection. High-dose VitD supplementation, particularly for risk groups, could be recommended to achieve and maintain optimal (range 40-60 ng/mL) serum 25-hydroxy vitamin D levels (marker of VitD status) both for COVID-19 prevention and treatment.
|*COVID-19[MESH]
|*Vitamin D Deficiency/drug therapy/epidemiology/prevention & control[MESH]